A Single, Ascending Dose Evaluation of the Safety, Pharmacokinetics of Methylone in Healthy Subjects

Launched by TRANSCEND THERAPEUTICS · Mar 4, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the safety and effects of a drug called methylone in healthy adults. Methylone is being researched as a potential treatment for Post Traumatic Stress Disorder (PTSD). In this study, participants will receive a single, increasing dose of methylone to see how their bodies respond to it and to monitor any side effects. The trial is currently looking for participants aged 25 to 55 who are in good health, with normal heart function and no major medical issues.

If you choose to participate, you can expect to undergo some health screenings to ensure you meet the eligibility requirements. It's important to note that individuals with certain health conditions, such as mental illnesses or those who have tested positive for drugs, will not be eligible to join the study. This trial is a great opportunity for those who want to contribute to research that could help improve treatments for PTSD while ensuring that participants are closely monitored for safety throughout the process.

Gender

ALL

Eligibility criteria

• Key Inclusion Criteria:
• • Healthy adult male or female aged 25 to 55 inclusive
• • Normal resting ECG
• • Normal hematologic and hepatic function
• • Normal renal function
• Key Exclusion Criteria:
• • Vital sign abnormalities
• • Positive urine drug screen at screening and / or Day -1
• • Current mental illness such as depression, anxiety disorder, schizophrenia or other psychotic disorders